Our approach was to employ VeroE6 cells, which contain a homozygous-allelic deletion of the IFN-α/β genes [24], [25], yet retain the ability to express IFN-induced genes such us ADAR1 and PKR, which can be activated during virus infection. The gene discussed is IFNA1; the disease is viral infectious disease.